The leading group of environmental medicine physicians in Germany say the H1N1 swine flu vaccine by Pandemrix® is unsuitable for patients with chronic multi-system illnesses such as chronic fatigue syndrome, fibromyalgia and multiple chemical sensitivity.
According to the Chemical Sensitivity Network (CSN) the German Professional Association of Environmental Medicine advises against the H1N1 vaccine by Pandemrix® for people with chronic multi-system illnesses.
Many who suffer from such illnesses are well aware that vaccines of any kind often cause exacerbation of symptoms and relapses and in some cases may have been a triggering factor in their illness.
The following statement (kindly translated by CSN) from the German Professional Association of Environmental Medicine outlines their position specifically on the Pandemrix® H1N1 vaccine providing a scientific rationale for each point on a substantial list of concerns.
Press release of the German Professional Association of Environmental Medicine (Deutscher Berufsverband der Umweltmediziner – DBU).
From 26. October 2009.
Swine flu [H1N1] vaccine is unsuitable for patients with chronic multi-system illnesses. Pandemrix® poses substantial health risk with respect to mass immunization programs due to the lack of proof of safety. Because of the producer’s release from liability by the German Federal Government (BRD), the risk of adverse reactions and/or permanent damage due to the vaccine rests with the patient.
The German Professional Association of Environmental Medicine (DBU) has, in spite of press releases from the BRD, the Paul-Ehrlich-Institute, as well as the vaccine producer’s assurances of safety, serious concerns relating to Pandemrix® (GlaxoSmithKline), the only vaccine which has been approved for mass vaccination by the BRD.
Comments